Optimized culturing yields high success rates and preserves molecular heterogeneity, enabling personalized screening for high-grade gliomas.
Saved in:
| Title: | Optimized culturing yields high success rates and preserves molecular heterogeneity, enabling personalized screening for high-grade gliomas. |
|---|---|
| Authors: | Posthoorn-Verheul C; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Fabro F; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, The Netherlands., Ntafoulis I; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., den Hollander C; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Verploegh ISC; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands., Balvers R; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Kers TV; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Hoogeveen J; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., van der Burg J; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Eussen B; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., de Klein A; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., Feller KJ; Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., Chien MP; Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., Dirven CMF; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Leenstra S; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Lamfers MLM; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands. m.lamfers@erasmusmc.nl. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 May 27; Vol. 9 (1), pp. 156. Date of Electronic Publication: 2025 May 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
